mlab20161102_8k.htm

 



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549   

 

FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

NOVEMBER 2, 2016
Date of Report (Date of earliest event reported)

 

MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

 

Commission File Number: 0-11740

 

COLORADO
(State or other jurisdiction of
incorporation)

 

84-0872291
(I.R.S. Employer
Identification No.)


 

12100 WEST SIXTH AVENUE,

LAKEWOOD, COLORADO
(Address of principal executive offices)

 

  80228
(Zip Code)

 

Registrant’s telephone number, including area code: (303) 987-8000

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

|_|

  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

|_|

  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

|_|

  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

|_|

  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

 
 

 

 

ITEM 5.07

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

The Annual Meeting of Shareholders of Mesa Laboratories, Inc. was held on November 2, 2016. Of the 3,668,016 shares of common stock entitled to vote, 3,385,315 were represented either in person or proxy. Seven directors were elected to serve until the next Annual Meeting of Shareholders. The advisory vote to approve executive compensation was approved. The ratification of the appointment of EKS&H LLLP as the Company’s independent registered public accounting firm for the year ending March 31, 2017 was approved.

 

The seven directors elected were:

 

                   

Broker

 
   

For

   

Withheld

   

Non-Votes

 

John B. Schmieder

    2,774,048       265,040       346,227  

John J. Sullivan, Ph.D.

    3,029,747       9,341       346,227  

Michael T. Brooks

    3,027,118       11,970       346,227  

H. Stuart Campbell

    3,025,888       13,200       346,227  

Robert V. Dwyer

    3,026,680       12,408       346,227  

Evan C. Guillemin

    3,026,936       12,152       346,227  

David M. Kelly

    3,025,347       13,741       346,227  

 

The advisory vote to approve executive compensation was approved by the following vote:

 

                             

Broker

 
     

For

   

Against

   

Abstain

   

Non-Votes

 
        2,847,872       68,222       122,994       346,227  

 

The appointment of EKS&H LLLP as the Company’s independent registered public accounting firm for the year ending March 31, 2017 was approved by the following vote:

   

                             

Broker

 
     

For

   

Against

   

Abstain

   

Non-Votes

 
        3,198,417       1,594       185,304       --  

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

DATE: November 2, 2016

 

Mesa Laboratories, Inc.

 

            ( Registrant)  
       

 

 

 

 

 

 

/s/ John J. Sullivan

 

 

BY:

John J. Sullivan,

 

 

 

President and Chief Executive Officer